| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Pimecrolimus | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Interferon | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Cytoplasmic lambda chain | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Interferon alfacon-1 | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Colony-stimulating factor, granulocyte-monocyte | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Interferon alfa-2b | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Colony stimulating factor | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Amifostine | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| MabCampath | Has disposition | False | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Colony-stimulating factor, granulocyte-macrophage | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Apremilast | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Immunosuppressant | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Mycophenolic acid | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Interferon alfa-n1 lymphoblastoid | Has disposition | False | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Interferon beta-1b | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Baricitinib | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Natalizumab | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Aldesleukin | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Interferon gamma | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Pidotimod | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Immune enhancement agent | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Inolimomab | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Interferon alfa | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Glatiramer | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Palivizumab | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Arcitumomab | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Fingolimod hydrochloride | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Interferon gamma-1b | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Trastuzumab emtansine | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Peginterferon alfa-2b | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Rabbit anti-human T-lymphocyte globulin | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Gemtuzumab ozogamicin | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement component 1q antibody | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement component C6 | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Active complement enzyme of alternative pathway | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement component C1 | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Factor I | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement component fragment | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Substance with complement inhibitor mechanism of action (substance) | Has disposition | False | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement component | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement component C7 | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Active complement enzyme of terminal pathway | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement activator | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Inactivated complement enzyme | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Active C5b67 | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement factor | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement component C3 | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement 2 allotype | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement component C5 | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement component C3d,g | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement component C5b | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| C3(H20)Bb | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Active C4b2a | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| C>5b678< inhibitor | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Active C5b6789 | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement allotype | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Human C1 esterase inhibitor | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Desarginisated complement enzyme | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Properdin | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement component C2b | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| C1r: C1s: C1 - Complement component 1r: Complement component 1s: Complement component 1 inhibitor activation complex | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Active complement enzyme of classic pathway | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement component C2 | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Properdin native | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Lymphocyte antigen CD46 | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement component C9 | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Properdin convertase, complement component | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement component iC3b | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement component 3bBbP activation complex | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Factor H | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement component, alternate pathway | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Homologous restriction factor | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Recombinant C1 esterase inhibitor | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement related substance | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Factor B | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement enzyme, active | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement component C1r | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement component C4b | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement component iC3 | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Active C4b | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Active C5b678 | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Substance with C1 esterase inhibitor mechanism of action | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Decay accelerating factor | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement, thermolabile serum protein complex with cytotoxic effect | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Active C5b | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement regulator | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Active C3bBb | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement regulatory factor | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Factor B allotype | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Active C4b2a3b | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement component C3g | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement component C1q | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement component C4d | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement component C4 | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Active C3b | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement regulatory protein, plasma | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement component, precursor | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement component C1s | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement component, classic pathway | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| C>5b67< inhibitor | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  | 
| Complement factor D | Has disposition | True | Immunomodulator | Inferred relationship | Existential restriction modifier |  |